Ocugen, Inc. (OCGN) Balance Sheet
As of 2026-06-30 (10-Q), Ocugen, Inc. (OCGN) reported total assets of $124.2M, total liabilities of $140.8M and shareholders' equity of -$16.6M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $100.4M. Long-term debt: $1.7M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
OCGNOcugen, Inc.Follow OCGN — free
—
Price chart with a free account
- Market cap
- 250.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 30.9 | 31.9 | 7.1 | 1.6 | 7.4 | 24.0 | 95.0 | 77.6 | 39.5 | 58.8 | 18.9 | 100.4 | |
| Short-term investments | — | — | 0.9 | — | — | — | 0.0 | 13.4 | 0.0 | — | — | — | |
| Current assets | 31.2 | 32.1 | 8.2 | 1.9 | 15.8 | 25.9 | 102.6 | 98.5 | 43.0 | 61.7 | 24.3 | 106.7 | |
| Total assets | 36.8 | 36.1 | 11.0 | 2.5 | 16.8 | 27.4 | 105.8 | 108.6 | 64.5 | 82.4 | 43.5 | 124.2 | |
| Current liabilities | 6.4 | 5.2 | 3.8 | 14.1 | 4.5 | 3.6 | 7.0 | 28.5 | 17.1 | 21.6 | 23.0 | 133.1 | |
| Long-term debt | — | — | — | 1.0 | 1.1 | 1.8 | 1.7 | 2.3 | 2.8 | 27.3 | 27.5 | 1.7 | |
| Short-term debt | — | — | — | 7.5 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 1.3 | 1.3 | 0.0 | |
| Total liabilities | 8.6 | 22.5 | 22.3 | 15.2 | 5.8 | 5.8 | 9.9 | 34.7 | 24.0 | 52.8 | 55.7 | 140.8 | |
| Shareholders' equity | 28.2 | 13.6 | 4.4 | -12.7 | 11.0 | 21.6 | 91.2 | 74.0 | 40.6 | 29.6 | -12.2 | -16.6 |
USD millions · SEC XBRL
Ocugen, Inc. — questions
- How much cash does Ocugen, Inc. have?
- $100.4M in cash and cash equivalents as of 2026-06-30.
- How much debt does Ocugen, Inc. have?
- $1.7M of long-term debt and $20000 due within a year as of 2026-06-30.
- What are Ocugen, Inc.'s total assets?
- $124.2M as of 2026-06-30.
- What is Ocugen, Inc.'s shareholders' equity?
- -$16.6M as of 2026-06-30.
Every figure on this page comes from Ocugen, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.